Investigating how a specific protein affects bone loss as we age
Role of Hypoxia-inducible factor-2α signaling in age-induced bone loss
This study is looking at how a specific protein called HIF-2α affects bone loss as we age, with the goal of finding new ways to help older adults keep their bones strong and healthy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-11037775 on NIH RePORTER |
What this research studies
This research explores the role of hypoxia-inducible factor-2α (HIF-2α) in the process of bone loss associated with aging. It aims to identify the mechanisms that lead to osteoporosis, a condition where bones become weak and brittle, particularly in older adults. By understanding how HIF-2α signaling changes with age, the researchers hope to develop new therapies that can reverse bone loss and improve overall bone health. The study will involve examining the cellular processes that contribute to bone deterioration and how they can be targeted for treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults experiencing or at risk of osteoporosis and related bone health issues.
Not a fit: Patients who are younger than 21 or those without age-related bone loss may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that prevent or reverse age-related bone loss, improving quality of life for older adults.
How similar studies have performed: Previous research has shown promising results in targeting similar pathways for improving bone health, indicating potential for success in this approach.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Mendoza, Sarah Vanessa — University of California at Davis
- Study coordinator: Mendoza, Sarah Vanessa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.